Krebs Biochemicals & Industries

quarterly
yearly
ParticularsJun '21Sep '21Dec '21Mar '22Jun '22
Revenue6.7611.9821.8119.1610.64
Expenses14.7021.1833.1330.9818.60
EBITDA-7.94-9.20-11.32-11.82-7.96
EBIT-9.36-10.62-12.74-13.87-9.65
Profit Before Tax-9.42-10.85-12.94-11.31-8.14
Net Profit-9.42-10.85-12.94-11.31-8.14
Financial Ratios
Operating Profit Margin-117.46%-76.79%-51.90%-61.74%-74.81%
Net Profit Margin-139.35%-90.57%-59.33%-59.03%-76.50%
Earning Per Share (Diluted)-4.37-5.05-6.00-5.23-3.77
Dividends Per ShareNANANANANA
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.3.6
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI